One Injection, Three Modalities
Combining diagnostic imaging, radiation therapy, and chemotherapy into a single intratumoral agent is designed to reduce the number of interventions a patient requires while compounding therapeutic effect.
This next-generation compound is built on the same self-nanotechnology carrier platform as UMIPIC: chemotherapeutic haptens and a sustained-release matrix form the base, with an added radiotherapeutic/imaging component that lets clinicians track drug retention and tumor response in real time while the compound continues to deliver localized radiation and chemotherapy.
This triple-function drug is currently under patent protection and in early pipeline development.
